114,456

$ 25,359

Exercise price

$ 3.17

Net proceeds

$ 4,500,000

Issued share purchase warrants

4,551,019

Common stock shares sold

1,633,987

Reimbursed amount for expenses

$ 70,000

Purchase price

$ 3.06

Description of salary of CFO

subject to annual increases of 1.25 x the annual inflation rate as determined by the US Federal Reserve Board, an option grant for the issuance of up to 50,000 common shares vested over three years, and annual performance milestone bonuses of up to 35% during the first year, 40% during the second year and thereafter up to 50% of the base salary. Should Mr. Shankman be terminated without cause, after an initial six months with the Company, he will be entitled to severance pay equal to two (2) months base salary, with such severance pay increasing by a month for each completed year of employment. Mr. Shankman will also be entitled to medical and dental benefits equal in value to up to $2,000 per month and four (4) weeks of paid vacation

Subsequent Events (Details Narrative) - USD ($)					1 Months Ended	12 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Nov. 05, 2024	Oct. 08, 2024	Sep. 04, 2024	Jul. 15, 2024	Oct. 16, 2024	Aug. 31, 2023
Common stock shares sold						114,456
Subsequent Event [Member]
Gross proceeds		$ 25,359
Stock options granted to employees	12,000
Exercise price	$ 3.17
Common stock shares sold		8,402
Subsequent Event [Member] \| H.C. Wainwright & Co. LLC [Member]
Gross proceeds			$ 5,000,000.0
Net proceeds			$ 4,500,000
Description of warrant issuance					We also issued HCW warrants to purchase up to 57,190 shares at an exercise price of $3.825 per share
Issued share purchase warrants			4,551,019
Purchase common stock shares			4,551,019
Common stock shares sold			1,633,987
Percent of gross proceeds			7.00%
Reimbursed amount for expenses			$ 70,000
Closing fees			$ 15,950
Purchase price			$ 3.06
Exercise price			$ 3.06
Executive Management Agreement [Member]
Annual salary of CFO				$ 120,000
Description of salary of CFO				subject to annual increases of 1.25 x the annual inflation rate as determined by the US Federal Reserve Board, an option grant for the issuance of up to 50,000 common shares vested over three years, and annual performance milestone bonuses of up to 35% during the first year, 40% during the second year and thereafter up to 50% of the base salary. Should Mr. Shankman be terminated without cause, after an initial six months with the Company, he will be entitled to severance pay equal to two (2) months base salary, with such severance pay increasing by a month for each completed year of employment. Mr. Shankman will also be entitled to medical and dental benefits equal in value to up to $2,000 per month and four (4) weeks of paid vacation